Senior Vice President and Head of Clinical Development
Iterum Therapeutics
Disclosure(s): Iterum Therapeutics: Employee, Employee, Stocks/Bonds (Public Company), Stocks/Bonds (Public Company)
Steven I. Aronin, MD, FACP, FIDSA is Senior Vice President and Head of Clinical Development at Iterum Therapeutics. Dr. Aronin earned his undergraduate degree from UCLA and his medical degree from Ross University School of Medicine. He completed his training in Primary Care/Internal Medicine as well as his fellowship in Infectious Disease at Yale University School of Medicine. He worked full-time as an Infectious Disease clinician from 1997-2017 at Waterbury Hospital in Waterbury, CT where he was Section Chief, Hospital Epidemiologist, and Scientific Director for the Yale-Waterbury Internal Medicine Residency Program. Dr. Aronin is Associate Clinical Professor of Medicine at Yale University Schools of Medicine, a fellow of the American College of Physicians, a fellow of the Infectious Disease Society of America, and past president of the CT Infectious Disease Society. Dr. Aronin joined Iterum Therapeutics in 2017. As Senior Vice President and Head of Clinical Development, Dr. Aronin has overseen the Phase III programs for sulopenem.